Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dragonfly Therapeutics
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Stanford University
Bristol-Myers Squibb
Filamon LTD
Astellas Pharma Inc
Novartis
Fondazione del Piemonte per l'Oncologia
PMV Pharmaceuticals, Inc
Novartis
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
UMC Utrecht
AstraZeneca
BeOne Medicines
Aveni Foundation
Monte Rosa Therapeutics, Inc
Genmab
Thomas Jefferson University
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Hummingbird Bioscience
University of California, Davis
Memorial Sloan Kettering Cancer Center
Replimune Inc.
Hospices Civils de Lyon
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Carevive Systems, Inc.
University of Pennsylvania
Duke University
Washington University School of Medicine
University of Florida
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Clasp Therapeutics, Inc.
Tianjin Medical University Cancer Institute and Hospital